Effect Of PRF Versus Xenograft In Closed Sinus Lift.

Prf Controlled, Randamized Clinical Trial of THE EFFECT OF PLATELET RICH FIBRIN( PRF ) VERSUS XENOGRAFT IN CLOSED SINUS LIFT AND IMLANT PLACEMENT ON IMPLANT STABILITY IN PATIENTS WITH MISSING MAXILLARY PREMOLAR.

Indirect sinus lift with used PRF as a graft material versus xenograft

Study Overview

• Status: Unknown
• Conditions: Implant or Graft; Rejection
• Intervention / Treatment: Other: Prf

Detailed Description

Crestal incision and reflect the tissue until exposure of the bone, then use drilling to make osteotomy. Then use sutable osteotomes to elevate the sinus floor, then pack of Prf or bone graft in the osteotomy and implant placement . Then closed the flap and suturing.

• Study Type: Interventional
• Enrollment (Anticipated): 10
• Phase: Not Applicable

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 25 years to 45 years (Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Edentulous area and bone high at least 5-6 mm below the maxillary sinus at maxillary premolar.
• Good oral hygiene.

Exclusion Criteria:

• bad oral hygiene.
• patient with systemic disease that may affect normal healing
• pregnant patients.
• patients with bone diseases and presence of periapical pathology affecting the neighboring teeth.
• Heavy smoker more than 20 cigarettes per day

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: Used of PRF in clsed sinus lifting; Used of PRF in closed sinus lifting with implant placement	Other: Prf; Take 10 cc blood from patient and gain prf
No Intervention: Closed sinus with xenograft; used of xenograft in closed sinus lift with implant placement.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Primary stability by ostell device	Implant stability will be mesured by ostell device, implant stability will be mesured intra operative at 0 ( time of implant placement ) and 2, 4, 6, 10 and 12 weeks after surgery	up to 3 months

Collaborators and Investigators

• Sponsor: Mahmoud adel shaaban

Study record dates

Study Major Dates

• Study Start (Anticipated): October 1, 2018
• Primary Completion (Anticipated): August 30, 2019
• Study Completion (Anticipated): August 30, 2019

Study Registration Dates

• First Submitted: September 16, 2018
• First Submitted That Met QC Criteria: September 25, 2018
• First Posted (Actual): September 26, 2018

Study Record Updates

• Last Update Posted (Actual): September 26, 2018
• Last Update Submitted That Met QC Criteria: September 25, 2018
• Last Verified: September 1, 2018

More Information

Terms related to this study

• Other Study ID Numbers: Cairo Univ.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No